Vestibular schwannoma clinical prognostic factors and nomogram construction using SEER database [0.03%]
基于SEER数据库听神经瘤临床预后因素分析及列线图的构建
Yuyu Wei,Jialong Tian,Xiaojun Pang et al.
Yuyu Wei et al.
Objective: This study aimed to delineate the long-term overall survival (OS) landscape and identify factors associated with OS in a large, population-based cohort of patients diagnosed with vestibular schwannoma (VS). ...
Prolonged neoadjuvant hormonal therapy enhances IL-17 A/STAT3-mediated inflammation in prostate cancer [0.03%]
长期使用新辅助激素治疗会增强前列腺癌中IL-17A/STAT3介导的炎症反应
Yirui Wei,Yifan Chu,Siqi Wang et al.
Yirui Wei et al.
Objective: To investigate the impact of neoadjuvant hormonal therapy (NHT) on interleukin‑17 A (IL‑17 A) signaling and inflammation in prostate cancer (PCa), and to explore the role of the IL‑17 A/signal transducer and...
Role of microRNA-183 based theranostics through targeting TPM1 in bladder cancer [0.03%]
靶向TPM1的基于miR-183膀胱癌诊疗研究进展
Samah Mamdouh,Tarek Aboushousha,Eman Hemida et al.
Samah Mamdouh et al.
Background: MicroRNA-183 (miR-183-5p), a noncoding RNA, is upregulated in bladder carcinoma (BC). Although it has been implicated in oncogenesis, its precise regulatory effects and biological functions remain unclear. Tro...
Extent of reoperation predicts survival in recurrent IDH-wildtype glioblastoma based on institutional data and individual patient data meta analysis [0.03%]
基于机构数据和患者个体层面的meta分析评估IDH野生型复发胶质母细胞瘤二次手术范围与生存期的关系
Alim Emre Basaran,Ann-Catalin Wellkisch,Erdem Güresir et al.
Alim Emre Basaran et al.
Background: Glioblastoma (GB) is the most aggressive brain tumor, characterized by rapid progression and poor prognosis. Despite initial multimodal treatment options, therapeutic options become more limited upon recurrenc...
Correction: Rutin suppresses the malignant biological behavior of gastric cancer cells through the Wnt/β-catenin pathway [0.03%]
rutin通过Wnt/β-catenin信号通路抑制胃癌细胞恶性生物学行为纠正版
Hui Huang,Jianguo Shi,Wei Chen et al.
Hui Huang et al.
Published Erratum
Discover oncology. 2025 Nov 13;16(1):2083. DOI:10.1007/s12672-025-03537-5 2025
Causal relationships between blood metabolites and glioblastoma risk: a large-scale Mendelian randomization study [0.03%]
基于大样本的孟德尔随机化研究揭示血液代谢产物与胶质母细胞瘤发病风险间的因果关系
Lin Huang,Yazhou Tang,Yali Tan et al.
Lin Huang et al.
Background: Glioblastoma multiforme (GBM) represents the most common and lethal primary brain tumor with incompletely understood pathogenesis. This study aims to systematically evaluate the causal relationships between bl...
Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma [0.03%]
基于蛋白质组的孟德尔随机化研究确定FCRL3和LY9是淋巴瘤潜在治疗靶点
Qianqian Guo,Juanjuan Shang,Bingyu Liu et al.
Qianqian Guo et al.
Background: Lymphoma is a common hematologic malignancy with limited treatment options. The research objective was to ascertain plasma proteins that could be targeted for lymphoma treatment. ...
Identification of 5mC regulatory factors mediating methylation patterns and prognosis models in head and neck squamous cell carcinoma [0.03%]
头颈鳞状细胞癌中表观遗传修饰模式及预后模型的建立与分析
Yanwei Li,Yunfeng Cao,Nuerbiyamu Maimaitiyiming et al.
Yanwei Li et al.
Background: This study explores the role of 5mC regulatory genes in head and neck squamous cell carcinoma (HNSCC), focusing on their association with tumor progression, metastasis, and prognosis. A prognostic model was al...
Investigating the effect of stearoyl-coenzyme desaturase 1 Inhibition on inflammatory and anti-inflammatory patterns in luminal A breast cancer patients' peripheral blood mononuclear cells [0.03%]
探究棕榈油酸辅酶A去饱和酶1抑制对腔A乳腺癌患者外周血单个核细胞炎性和抗炎模式的影响
Neda Naghashi,Esmaeil Babaei,Zohreh Sanaat et al.
Neda Naghashi et al.
Purpose: Breast cancer (BC) is the most prevalent female cancer globally. A key feature of cancer cells is a remarkable alteration in lipid composition, notably an enrichment in monounsaturated fatty acids. This change re...
The efficacy and safety of mirvetuximab soravtansine for the treatment of recurrent ovarian cancer: an update systematic review and meta-analysis [0.03%]
mirvetuximab soravtansine治疗复发性卵巢癌的疗效和安全性：系统性回顾和meta分析的更新研究
Qiling Dai,Jiawen Tang,Ting Du et al.
Qiling Dai et al.
Introduction: This meta-analysis aims to evaluate the efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with recurrent ovarian cancer, with particular emphasis on those with platinum-resistant disease. ...